Spurs Sports and Entertainment and Canon Medical Partnership To Benefit High-Performance Athletes and Weekend Warriors

Spurs Sports and Entertainment: announced today a new partnership between Canon Medical Systems USA, Inc. and the San Antonio Spurs.

Spurs Sports and Entertainment is the premier provider of sports and entertainment in South Texas. They owns and operate the San Antonio Spurs, Austin Spurs (NBA G League), San Antonio FC (USL) and also manages the day-to-day operations of the AT&T Center and Toyota Field.

As part of the partnership, Canon Medical and the Spurs will collaborate on advancing medical imaging innovation to benefit everyone from high-performance athletes to weekend warriors and beyond.

“The Spurs are thrilled to partner with Canon Medical because they believe in using their technology to better humanity,” said RC Buford, CEO of Spurs Sports & Entertainment.  “We want to work with curious companies who have a learner mindset and are willing to bring new ideas forward. With a focus on today, we are always planning for tomorrow, and we believe this relationship will help us compete at the highest level.”

The collaboration between Canon Medical and SS&E began in 2016 after Buford and a group of Spurs executives visited Ciutat Esportiva Joan Gamper, the training complex for FC Barcelona.  In his visit, Buford learned how Canon Medical was at the forefront of diagnostic imaging. Since then, the Spurs identified Canon Medical as a critical part of their player care program and have been participating in Canon Medical’s professional education programs.

“At Canon Medical, our ‘Made For Life’ philosophy drives us to deliver innovative solutions to improve the quality of life for all people,” said Yuji Hamada, CEO of Canon Medical Systems USA, Inc. “The San Antonio Spurs embody that belief, which makes them an ideal partner. As the Spurs continue to perform as one of the highest-level teams in U.S. professional sports, it is our goal to work with the best clubs in the U.S. and globally so that we can take what we learn from elite athletes and apply it to all people.”

Additional information about the partnership will be highlighted through the Spurs social channels in the coming months.  Click here to watch a video on the partnership.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.